Researchers examined the risk for serious infection among patients with atopic dermatitis treated with Janus kinase inhibitors vs Th2 cytokine inhibitors.
Interest in cytokine modulation has expanded further with the success of interleukin (IL) inhibitors, as well as inhibitors of kinases involved in signalling downstream of cytokine receptors ...
During a live event, Catherine J. Lee, MD, MS, discussed the mechanism of action of approved therapies for chronic ...
Interleukin-23 inhibitors may be able to reduce the risk of developing psoriatic arthritis among patients with psoriasis, ...
It remains unclear, however, which proportion of this increased risk can be attributed to the use of cytokine inhibitors, to the underlying disease, or to other immunosuppressive medications ...
Hosted on MSN11mon
Researchers find B cells drive responses of other immune cells, can be modified to prevent multiple sclerosis symptomscalled BTK inhibitors, does just that. These agents slow overactive B cell respiration and "calm down" B cells of MS patients, so that they don't release the same abnormal cytokine profile that ...
Cytokine interaction networks drive immune function ... cell attachment factors, pH buffer, protease inhibitors, vitamins, minerals, lipids, and a variety of undefined components. Serum also protects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results